Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment

S. Fuschillo; E. Heffler; M. Maniscalco

doi:10.2217/bmm-2020-0075

Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment

S. Fuschillo, E. Heffler, M. Maniscalco

Research output: Contribution to journal › Review article › peer-review

Abstract

No abstract available

Original language	English
Pages (from-to)	499-502
Number of pages	4
Journal	Biomarkers in Medicine
Volume	14
Issue number	7
DOIs	https://doi.org/10.2217/bmm-2020-0075
Publication status	Published - 2020

Access to Document

10.2217/bmm-2020-0075

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086746743&doi=10.2217%2fbmm-2020-0075&partnerID=40&md5=5c4cc40f2fc3ce3bb88518f73c9b6911

Cite this

@article{2434127da9a7411c9684e103f6ac8dce,

title = "Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment",

abstract = "No abstract available",

author = "S. Fuschillo and E. Heffler and M. Maniscalco",

note = "Export Date: 7 December 2020",

year = "2020",

doi = "10.2217/bmm-2020-0075",

language = "English",

volume = "14",

pages = "499--502",

journal = "Biomarkers in Medicine",

issn = "1752-0363",

publisher = "Future Medicine Ltd.",

number = "7",

}

TY - JOUR

T1 - Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment

AU - Fuschillo, S.

AU - Heffler, E.

AU - Maniscalco, M.

N1 - Export Date: 7 December 2020

PY - 2020

Y1 - 2020

N2 - No abstract available

AB - No abstract available

U2 - 10.2217/bmm-2020-0075

DO - 10.2217/bmm-2020-0075

M3 - Review article

VL - 14

SP - 499

EP - 502

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 7

ER -

Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment

Abstract

Access to Document

Fingerprint

Cite this